Ryan T. Cirz - Concepedia

Author

Ryan T. Cirz

Scripps Research Institute ORCID

Also Known As

R. Cirz, R.T. Cirz, Ryan Cirz, Ryan T Cirz, Ryan T. Cirz

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Scripps Research Institute University of Florida

About

Ryan T. Cirz is an author at Scripps Research Institute specializing in medicine, microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Health Sciences	3	3	943
3	Biochemistry	2	2	99
4	Natural Sciences	1	1	24
5	Epidemiology	1	1	18

Ryan T. Cirz

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance Ryan T. Cirz, Jodie K. Chin, David R. Andes, PLoS Biology GeneticsMolecular BiologyAntimicrobial ChemotherapyAntibiotic ResistanceTreatment Resistance	2005	575
Defining the <i>Pseudomonas aeruginosa</i> SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin Ryan T. Cirz, Bryan M. O’Neill, Jennifer Hammond, Journal of Bacteriology	2006	267
Complete and SOS-Mediated Response of <i>Staphylococcus aureus</i> to the Antibiotic Ciprofloxacin Ryan T. Cirz, Marcus B. Jones, Neill A. Gingles, Journal of Bacteriology BacteriologyAntibiotic ResistanceBacterial PathogensDrug ResistanceInfection Control	2006	264
Structural and Initial Biological Analysis of Synthetic Arylomycin A<sub>2</sub> Tucker C. Roberts, Peter A. Smith, Ryan T. Cirz, Journal of the American Chemical Society	2007	114
Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria Ryan T. Cirz, Floyd E. Romesberg Antimicrobial Agents and Chemotherapy Molecular BiologyHypermutator BacteriaAntimicrobial ChemotherapyAntibiotic ResistanceMmr-defective Escherichia Coli	2005	104
Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model George L. Drusano, W. Liu, Steven Fikes, The Journal of Infectious Diseases	2014	77
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety Frederick Cohen, James B. Aggen, Logan D. Andrews, ChemMedChem Antibiotic AdjuvantCardiovascular PharmacologyPharmacotherapyAntimicrobial ChemotherapyPharmaceutical Chemistry	2019	75
Potent LpxC Inhibitors with <i>In Vitro</i> Activity against Multidrug-Resistant Pseudomonas aeruginosa Kevin M. Krause, Cat M. Haglund, Christy M. Hebner, Antimicrobial Agents and Chemotherapy	2019	59
Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase Logan D. Andrews, Timothy R. Kane, Paola Dozzo, Journal of Medicinal Chemistry	2019	35
Exploring the active site of the <i>Streptococcus pneumoniae</i> topoisomerase IV–DNA cleavage complex with novel 7,8-bridged fluoroquinolones Ivan Laponogov, Xiao-Su Pan, Dennis A. Veselkov, Open Biology	2016	27

Page 1